previous compound ID: 1898 next compound
InChIKey: QYSPLQLAKJAUJT-UHFFFAOYSA-N
SMILES: CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "J Goepp" "B Kus" "R Robert" "DY Thomas" "D Rotin" "J Liao" "JW Hanrahan" "E Matthes" "SD Macknight"

chemical graph of compound 1898





CID is 54676228
synonyms found at PubChem are:
piroxicam, 36322-90-4, Feldene, Piroxicamum, Pyroxycam, Roxicam, Piroftal, BAXO, Artroxicam, Bruxicam, Caliment, Flogobene, Geldene, Improntal, Larapam, Piroflex, Reudene, Roxiden, Sasulen, Solocalm, Erazon, Pirkam, Riacen, Zunden, piroxicam usp, Roxam, CP-16171, Piroxicam betadex, Piroxicamum [INN-Latin], CP 16171, CHF 1251, Pipoxicam, Felden, Akten, Apo-Piroxicam, Feldene Fast, Feldene Gel, UNII-13T4O6VMAM, Feldene (TN), NSC 666076, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, Piroxicam (Feldene), CCRIS 3719, 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide, C15H13N3O4S, Piroxicam [USAN:BAN:INN:JAN], 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, EINECS 252-974-3, AK1015, CP16171, BRN 0627692, 13T4O6VMAM, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid, 4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, MLS000069644, CHEBI:8249, QYSPLQLAKJAUJT-UHFFFAOYSA-N, 4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide, NSC666076, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German], 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, NCGC00015823-02, SMR000035997, CAS-36322-90-4, DSSTox_CID_1170, P 5654, DSSTox_RID_75990, DSSTox_GSID_21170, Rosiden, 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1, (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1, 4-Hydroxy-2-methyl-3[pyrid-2-yl-carbamoyl]-2H-1,2-benzothiazine 1,1-dioxide, (4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e, (4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, (Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide, 1488516-58-0, SR-01000000199, Roxam;Feldene, 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1?^{6},2-benzothiazine-3-carboxamide, Piroxicam,(S), Brexidol (TN), Feldoral (TN), Proponol (TN), Reumador (TN), Prestwick_573, Hotemin (TN), Mobilis (TN), Brexin (TN), Erazon (TN), Exipan (TN), Felden (TN), Tracam (TN), Vurdon (TN), Veral (TN), Piroxicam [USAN:USP:INN:BAN:JAN], Pirox von ct (TN), Spectrum_001115, Tocris-0960, Opera_ID_442, AC1NQX1P, AC1NSM2R, AC1Q3XLJ, Prestwick0_000211, Prestwick1_000211, Prestwick2_000211, Prestwick3_000211, Spectrum2_001287, Spectrum3_000780, Spectrum4_000968, Spectrum5_001445, Lopac-P-5654, Feldene, Roxam, Piroxicam, CHEMBL527, D00IBN, AC1L1J3Z, BIDD:PXR0154, Lopac0_000900, Oprea1_714707, SCHEMBL13462, SCHEMBL21350, BSPBio_000221, BSPBio_001030, BSPBio_002460, KBioGR_000370, KBioGR_001315, KBioSS_000370, KBioSS_001595, MLS000038002, MLS001148207, MLS001304054, MLS004774122, DivK1c_000369, SPECTRUM1500491, SPBio_001293, SPBio_002142, Piroxicam (JP15/USP/INN), Piroxicam (JP17/USP/INN), BPBio1_000245, GTPL7273, Piroxicam, >=98% (TLC), SCHEMBL3703617, Piroxicam for system suitability, CHEMBL1518938, DTXSID5021170, BCBcMAP01_000176, BDBM85245, CTK7I2700, HMS501C11, KBio1_000369, KBio2_000370, KBio2_001595, KBio2_002938, KBio2_004163, KBio2_005506, KBio2_006731, KBio3_000719, KBio3_000720, KBio3_001680, KS-00000JBT, MolPort-001-888-120, MolPort-035-874-705, NINDS_000369, Piroxicam 1.0 mg/ml in Methanol, Bio1_000363, Bio1_000852, Bio1_001341, Bio2_000355, Bio2_000835, HMS1362D11, HMS1568L03, HMS1792D11, HMS1920H22, HMS1990D11, HMS2089B06, HMS2092A05, HMS2095L03, HMS2231G03, HMS3262D22, HMS3267I03, HMS3369B07, HMS3403D11, HMS3429L03, HMS3655C04, HMS3712L03, Pharmakon1600-01500491, BCP02919, HY-B0253, NSC_4856, Tox21_110231, Tox21_200151, Tox21_500900, ANW-43611, BBL016493, CCG-36403, MFCD00057317, NSC757284, s1713, STK177288, ZINC12466469, ZINC51133897, ZINC87724780, AKOS000714958, AKOS025312555, AKOS026749939, Tox21_110231_1, AM84917, CS-2233, DB00554, KS-5322, LP00900, LS-7663, MCULE-1939282084, NSC-666076, NSC-757284, 3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, IDI1_000369, IDI1_002110, NCGC00015823-01, NCGC00015823-03, NCGC00015823-04, NCGC00015823-05, NCGC00015823-06, NCGC00015823-07, NCGC00015823-08, NCGC00015823-09, NCGC00015823-10, NCGC00015823-11, NCGC00015823-12, NCGC00015823-13, NCGC00015823-14, NCGC00015823-15, NCGC00015823-17, NCGC00015823-18, NCGC00021244-03, NCGC00021244-05, NCGC00021244-06, NCGC00021244-07, NCGC00021244-08, NCGC00021244-09, NCGC00188982-01, NCGC00257705-01, NCGC00261585-01, AC-24190, BAS 04381594, BC204217, NCI60_022912, SC-16825, ST069379, BCP0726000299, SBI-0050875.P004, AB0011706, AB2000240, AJ-111664, CAS_36322-90-4, CP-16,171, KB-284635, Piroxicam, meets USP testing specifications, ST2411449, TR-014899, EU-0100900, FT-0080892, FT-0630590, P1905, EN300-70724, A19556, C01608, D00127, J10253, M-9898, AB00052074-21, AB00052074-22, AB00052074_23, AB00052074_24, 322P904, SR-01000000199-3, SR-01000000199-5, SR-01000000199-9, W-106626, SR-01000000199-12, F0001-2399, Piroxicam, British Pharmacopoeia (BP) Reference Standard, Z1259192069, Piroxicam, European Pharmacopoeia (EP) Reference Standard, Piroxicam, United States Pharmacopeia (USP) Reference Standard, 3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1, (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1, Piroxicam, Pharmaceutical Secondary Standard; Certified Reference Material, 2-methyl-N-(pyridin-2-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, 2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide, 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l;{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide, 4-Hydroxy-3-(pyridin-2-yl-carbamoyl)-2-methyl-2H-1,2-benzothiazin-1,1-dioxide, N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, (E)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide, 1044566-76-8, 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4h-1,2-benzothiazin-4-one 1,1-dioxide, 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione, 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione, 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda,2-benzothiazine-1,1,4-trione, 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione, 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1,2-dihydro-1lambda,2-benzothiazine-3-carboxamide